Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • None of the SARS-CoV-2 Genetic Mutations Appear to Increase Transmissibility

NIPGR Research Fellow Jobs For Biotech/Biochem & Life Sciences

ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

None of the SARS-CoV-2 Genetic Mutations Appear to Increase Transmissibility
  • BiotechToday
  • World

None of the SARS-CoV-2 Genetic Mutations Appear to Increase Transmissibility

bioxone December 2, 2020December 2, 2020

SAGNIK NAG, Amity University, Kolkata

SARS-CoV-2 is a type of RNA virus, which can develop mutations by three different ways: by making mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell i.e. recombination, or they can be also induced by host RNA modification systems which are part of host immunity. Majority most of the mutations are neutral, while some or others can be a boon or can be detrimental to the virus. Both neutral and advantageous mutations can become random as they get passed down to descendant viruses. 

None of the mutations that are documented in the SARS-CoV-2 virus has a chance to increase its transmissibility in humans, according to a current study led by University College London researchers.  According to the first and corresponding author Dr. Lucy van Dorp, the number of SARS-CoV-2 genomes that have been generated for scientific research are staggering. They realized early on in the pandemic that the medical and research fraternity needs new approaches to analyze enormous amounts of data in close to real time to flag new mutations in the virus that could severely affect its transmission. The experimental analysis of viral genomes from over 48,000 people with COVID-19 from 98 countries is published by Nature Communications. 

To test and to cross-verify their experimental results and if the mutations can increase transmission of the virus, the researchers modeled the virus’ evolutionary tree, and analyzed whether a particular mutation was becoming progressively random within the branch of the evolutionary tree — The researchers couldn’t find any evidence that any of the common mutations are capable of increasing the virus’ transmissibility. Instead, they experimentally found most common mutations are neutral for the virus. This constitutes one mutation in the viral spike protein- D614G, which is widely reported as being a common mutation that may make the virus more transmissible. 

Also read: Ever wondered how the Rho protein really stops gene expression

References:

https://scitechdaily.com/good-covid-news-none-of-the-sars-cov-2-genetic-mutations-appear-to-increase-transmissibility/

https://creativecommons.org/

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Biotechnology and Biological Sciences Research Council CORONAVIRUS COVID-19 Infectious disease Newton Fund UK-China NSFC initiative public health SARS-CoV-2 spike protein university college London virology

4 thoughts on “None of the SARS-CoV-2 Genetic Mutations Appear to Increase Transmissibility”

  1. Sourav says:
    December 2, 2020 at 2:23 pm

    Much needed information….Thank you sagnik for such an amazing piece🙏🏻

    Reply
  2. Rohini Das says:
    December 2, 2020 at 2:30 pm

    Excellent work Sagnik! Keep up the good work!!😊

    Reply
  3. Rohini Das says:
    December 2, 2020 at 2:31 pm

    Excellent work Sagnik! Keep up the good work!!

    Reply
  4. Pingback: ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

bioxone December 2, 2020

Husna, Amity University Kolkata Oncolytic viruses are genetically engineered for the destruction of cancer or tumour-causing cells specifically. They’re delivered for treatment inside the body via intravenous injection. In 2015, one such oncolytic virus was approved by the FDA for treating skin cancer, melanoma. A major obstacle in the application of oncolytic adenoviruses is that […]

ADENOVIRUS

Related Post

  • BiotechToday
  • World

Arabidopsis thaliana- A hero in disguise?

bioxone November 1, 2020October 31, 2020

Shrayana Ghosh, Amity University Kolkata A hero in disguise, which was earlier set aside for not being medically useful, recently proved potent against breast cancer cell growth and, also doesn’t affect the division of normal cells. This could be a futuristic solution by being a very useful cancer chemotherapy treatment.  The ground-breaking discovery was made […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Comeback of tuberculosis- but its drug-resistant now!

BioTech Today July 3, 2021July 2, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University Tuberculosis is a major health concern in many low and middle-income countries. TB continues to be the top killer infectious disease in the world. In 2019 over 10.0 million people were affected with TB and 1.41 million deaths were attributed to it. TB affects all countries of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Invisible cancer risk in talc-based cosmetics

bioxone December 4, 2020December 4, 2020

Devyani Goswami, Amity University Kolkata More than 60% of cosmetics products are made up of talc to enhance the quality of the product. A two years (2018-2020) study concluded that every talc-based cosmetics products have a little amount of asbestos in them which can cause cancer, as many complaints were made stating women suffering from […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy